93 related articles for article (PubMed ID: 9128287)
21. Mystery Case: CNS posttransplant lymphoproliferative disorder.
Kesari NK; Sivakumar S; Kapadia AM; Chen W; Blieden CR; Venkatasubba Rao CP; Suarez JI
Neurology; 2017 Jul; 89(4):e32-e37. PubMed ID: 28739669
[No Abstract] [Full Text] [Related]
22. Cytologic findings in posttransplant lymphoproliferative disease.
Davey DD; Gulley ML; Walker WP; Zaleski S
Acta Cytol; 1990; 34(3):304-10. PubMed ID: 2343685
[TBL] [Abstract][Full Text] [Related]
23. Rapidly progressive post-transplant lymphoproliferative disease following withdrawal of sirolimus.
Mendelson M; Barday Z; Eastman R; Le Feuvre D; Candy S; Wu HT; Swanepoel C
S Afr Med J; 2012 Aug; 102(12):924-6. PubMed ID: 23498038
[TBL] [Abstract][Full Text] [Related]
24. Bone marrow involvement by lymphoproliferative disorders after solid-organ transplant.
Akar Özkan E; Özdemir BH; Yılmaz Akçay E; Terzi A; Karakuş S; Haberal M
Exp Clin Transplant; 2015 Apr; 13 Suppl 1():183-7. PubMed ID: 25894151
[TBL] [Abstract][Full Text] [Related]
25. Pediatric central nervous system posttransplant lymphoproliferative disorder.
Brennan KC; Lowe LH; Yeaney GA
AJNR Am J Neuroradiol; 2005 Aug; 26(7):1695-7. PubMed ID: 16091516
[TBL] [Abstract][Full Text] [Related]
26. Plasmacytic hyperplasia in age-related Epstein-Barr virus-associated lymphoproliferative disorders: a report of two cases.
Kojima M; Morita Y; Nakamura N; Shimizu K; Murayama K; Nakamura S
Pathol Res Pract; 2008; 204(4):267-72. PubMed ID: 18187262
[TBL] [Abstract][Full Text] [Related]
27. Primary cutaneous Epstein-Barr virus-related lymphoproliferative disorders in 4 immunosuppressed children.
Wallet-Faber N; Bodemer C; Blanche S; Delabesse E; Eschard C; Brousse N; Fraitag S
J Am Acad Dermatol; 2008 Jan; 58(1):74-80. PubMed ID: 17884243
[TBL] [Abstract][Full Text] [Related]
28. Complications of Immunosuppressive Therapy in Solid Organ Transplantation.
Katabathina V; Menias CO; Pickhardt P; Lubner M; Prasad SR
Radiol Clin North Am; 2016 Mar; 54(2):303-19. PubMed ID: 26896226
[TBL] [Abstract][Full Text] [Related]
29. The clinical and pathologic implications of plasmacytic infiltrates in percutaneous renal allograft biopsies.
Meehan SM; Domer P; Josephson M; Donoghue M; Sadhu A; Ho LT; Aronson AJ; Thistlethwaite JR; Haas M
Hum Pathol; 2001 Feb; 32(2):205-15. PubMed ID: 11230708
[TBL] [Abstract][Full Text] [Related]
30. Involvement of the gastrointestinal tract by Epstein-Barr virus--associated posttransplant lymphoproliferative disorders.
Nalesnik MA
Am J Surg Pathol; 1990; 14 Suppl 1():92-100. PubMed ID: 2158245
[TBL] [Abstract][Full Text] [Related]
31. Donor lymphocyte transfusion for the treatment of Epstein-Barr virus-associated lymphoproliferative disorder of the brain.
Nagafuji K; Eto T; Hayashi S; Oshima K; Maeda Y; Gondo H; Inamura T; Niho Y
Bone Marrow Transplant; 1998 Jun; 21(11):1155-8. PubMed ID: 9645581
[TBL] [Abstract][Full Text] [Related]
32. Posttransplant lymphoproliferative disorders in renal allograft recipients: report of 53 cases of a French multicenter study. PTLD French Working Group.
Caillard S; Lachat V; Moulin B
Transpl Int; 2000; 13 Suppl 1():S388-93. PubMed ID: 11112039
[TBL] [Abstract][Full Text] [Related]
33. Post-transplantation lymphoproliferative disorder: the spectrum of imaging appearances.
Scarsbrook AF; Warakaulle DR; Dattani M; Traill Z
Clin Radiol; 2005 Jan; 60(1):47-55. PubMed ID: 15642292
[TBL] [Abstract][Full Text] [Related]
34. Heart allograft involvement by posttransplant lymphoproliferative disorders: report from the PTLD. Int survey.
Khedmat H; Taheri S
Exp Clin Transplant; 2011 Aug; 9(4):258-64. PubMed ID: 21819371
[TBL] [Abstract][Full Text] [Related]
35. Epstein-Barr virus detection in sequential biopsies from patients with a posttransplant lymphoproliferative disorder.
Lager DJ; Burgart LJ; Slagel DD
Mod Pathol; 1993 Jan; 6(1):42-7. PubMed ID: 8381232
[TBL] [Abstract][Full Text] [Related]
36. Multifocal cranial plasmablastic lymphoma as a rare manifestation of posttransplant lymphoproliferative disorder.
Jenabi A; Mooraki A; Jabbari M; Shayanfar N; Ghods AJ; Ziari MB; Bastani B
Iran J Kidney Dis; 2012 Sep; 6(5):380-5. PubMed ID: 22976265
[TBL] [Abstract][Full Text] [Related]
37. Aspergillosis of the brain and paranasal sinuses in immunocompromised patients: CT and MR imaging findings.
Ashdown BC; Tien RD; Felsberg GJ
AJR Am J Roentgenol; 1994 Jan; 162(1):155-9. PubMed ID: 8273655
[TBL] [Abstract][Full Text] [Related]
38. Can kidney posttransplant lymphoproliferative disorder be detected in voided urine? A case report.
AbdullGaffar B; Kamal MO; Khalid M; Samuel R; AlAbsi N; AlAwadi F
Acta Cytol; 2010; 54(2):221-4. PubMed ID: 20391985
[TBL] [Abstract][Full Text] [Related]
39. Post-transplantation lymphoproliferative disorder of recipient origin in a boy with acute T-cell leukemia with detection of B-cell clonality 3 months before stem cell transplantation.
Kontny U; Boppana S; Jung A; Goebel H; Strahm B; Peters A; Dormann S; Werner M; Bader P; Fisch P; Niemeyer C
Haematologica; 2005 Nov; 90 Suppl():ECR27. PubMed ID: 16266918
[TBL] [Abstract][Full Text] [Related]
40. Central nervous system T-cell lymphoproliferative disorder in a patient with chronic active Epstein-Barr virus infection.
Ohga S; Takada H; Honda K; Inamura T; Gondo K; Ohshima K; Yamamoto M; Hara T
J Pediatr Hematol Oncol; 1999; 21(1):42-6. PubMed ID: 10029811
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
